WHO raises Worldwide alert on fake diabetes drugs in circulation ( Here’s What To Look Out For)

The World Health Organization (WHO) on Friday issued a public warning over the circulation of fake diabetes medications that have been on the market since 2022, impacting every part of the globe.

TheNewsGuru.com (TNG) reports that the health organization, in a statement, specifically mentioned countries such as the United Kingdom, the United States, and Brazil as those dealing with issues with these fake drugs.

The issue involves Ozempic, a drug which is sanctioned in the EU and contains the active ingredient semaglutide.

According to health organizations, the fake version is an exact replica of the genuine drug. Since it also reduces appetite, it’s being increasingly used for weight reduction.

WHO also stated that these fake medications might not have the correct dosage of active ingredients, potentially leading to uncontrolled blood sugar levels in diabetics.

It also mentioned that these fake drugs could have other active ingredients that are harmful to health.

Urging healthcare professionals, pharmacists, regulatory bodies, and the general public, WHO advises they stay alert.

The WHO advised that individuals should only purchase medications with a prescription from brick-and-mortar pharmacies, not online.

Patients are also encouraged to check that the insulin pen’s dosage markings are clear, the label is accurate, and there are no typos on the packaging.